Flow Cytometry Market Growth, Size and Trends

1. Flow Cytometry Market To Reach $10,065.4 Million by 2030 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The total flow cytometry market size was $4,874.1 million in 2021, which is likely to reach $10,065.4 million by 2030, propelling at an 8.4% CAGR from 2021 to 2030. This will mainly be because of the growth in drug development, increase in the demand for analysis in clinical diagnostics, and the usage of flow cytometry for research purposes. For instance, this technology is widely used in in-vitro molecular studies and cancer research. Healthcare centers accomplish immunophenotyping for the analysis of primary immunodeficiency ailments, lymphoma and leukemia, and paroxysmal nocturnal hemoglobinuria (PNH), and reporting of immunity status in patients with HIV contagions and other malignant diseases. For example, globally, about 20 million new cancer cases were reported in 2020, and this number will likely reach around 30 million by 2040. Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/flow-cytometry- market/report-sample Hence, a sum of $105 million was invested in 2019 and another $137 million in 2020 by a U.S. government organization for advancing cancer detection and diagnosis technologies. In the years to come, the bead-based category will witness the higher CAGR, around 9%, in the flow cytometry market, under segmentation by technology. In recent times, flow cytometric studies utilizing beads have become popular in numerous laboratory analytical processes. Hospitals and clinics are the leading end users of flow cytometry analytical tools. Clinics and hospitals deal with hundreds of patients daily because of the snowballing occurrence of ailments, many of which are now being diagnosed using flow cytometry. Geographical Analysis of Flow Cytometry Market • North America had the largest revenue share in the flow cytometry market in 2021. This is accredited to the presence of key healthcare administrations and research institutes, including four of the top five cancer research centers in the world. • Further, the pharmaceutical industry of the U.S. has continued to lead in the development of new medicines and medical research. Here, the technology is widely utilized for understanding the response of single cells to pipeline drug candidates and the complicated pathways that are involved in the cell–drug interaction. • Moreover, in Canada, 5,584 new medicines were aligned for numerous stages of assessment in 2019. Therefore, the increasing number of clinical trials for drug safety and efficacy evaluation push the growth of the market. 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. With a rise in healthcare investments and improvements in healthcare facilities, the biomedical R&D industry is forecast to expand significantly. For example, the total spending by Johnson & Johnson on R&D was $12.2 billion in 2020 and $14.7 billion in 2021. In all, the pharmaceutical business spent $83 billion in 2019 on R&D, and the count of the newly approved drugs for sale augmented by around 60% between 2010 and 2019. Therefore, the expansion of the flow cytometry market has resulted from the increasing investments in R&D by biotechnology and pharmacological firms and product launches and approvals. The research offers the size of the global flow cytometry market for the period 2017–2030. Market Segmentation by Technology Cell-Based Flow Cytometry Bead-Based Flow Cytometry Market Segmentation by Offering Instruments Reagents Software and Services Others Market Segmentation by Application Drug Discovery Cancer Diagnostics Stem Cell Therapy Hematology and Immunology Organ Transplantation Others Market Segmentation by End User Hospitals and Clinics Pharmaceutical and Biotechnology Companies Academic and Research Institutes Others Market Segmentation by Region North America Flow Cytometry Market • • • • • • • • • • • • • • • • • oBy technology oBy offering oBy application oBy end user 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. oBy country – U.S. and Canada Europe Flow Cytometry Market • oBy technology oBy offering oBy application oBy end user oBy country – Germany, U.K., Italy, Spain, France, and Rest of Europe Asia-Pacific (APAC) Flow Cytometry Market • oBy technology oBy offering oBy application oBy end user oBy country – China, India, Japan, Australia, South Korea, and Rest of APAC Latin America (LATAM) Flow Cytometry Market • oBy technology oBy offering oBy application oBy end user oBy country – Brazil, Mexico, and Rest of LATAM Middle East and Africa (MEA) Flow Cytometry Market • oBy technology oBy offering oBy application oBy end user oBy country – Saudi Arabia, South Africa, U.A.E., and Rest of MEA 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved